Concepedia

Brandi Reeves

BR

28

Publications

2.4K

Citations

21

H-Index

2002

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Levine Cancer Institute

Dana-Farber Cancer Institute

The University of Texas Southwestern Medical Center

Janssen Scientific Affairs (United States)

Brandi Reeves is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

2002–2024

28

Publications

28

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial

Peter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach et al. · Blood · 2020 · 653 citations · Full text

Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1

Charles L. Loprinzi, Brandi Reeves, Shaker R. Dakhil et al. · Journal of Clinical Oncology · 2011 · 268 citations · Full text

Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat et al. · The Lancet Oncology · 2018 · 235 citations

, , +7

Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study

Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat et al. · Blood Cancer Journal · 2019 · 210 citations · Full text

Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy

Brandi Reeves, Shaker R. Dakhil, Jeff A. Sloan et al. · Cancer · 2012 · 157 citations · Full text

Rows per page

1–5 of 28